AQP4 and optic neuritis: Both patients showing brainstem symptoms or isolated unilateral optic neuritis were positive for serum AQP4 antibody (Lana-Peixoto et al., 2018), and AQP4 antibodies have been proposed as a pathogenic and diagnostic biomarker for NMOSD (Berger et al., 2017).